Malignant Neoplasm — Trials

Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

90,685 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20,116
Recruiting: 10,894
Ph III recruiting: 1,280
Growth YoY: +12%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11,163)

clinicaltrialsPublishedShowing 51–59 of 59 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03752541	Efficacy and Safety Evaluation of BCMA-UCART	suspended	N/A	20	Bioray LaboratoriesINDUSTRY	1	May 20, 2022	clinicaltrials
NCT03081897	Regional Anaesthesia and Substance P in Head and Neck Cancer(SPRANC)	suspended	N/A	40	Charite University, Berlin, GermanyOTHER	1	Feb 4, 2022	clinicaltrials